Chordate Medical has signed an agreement with another clinic for the Ozilia treatment for chronic migraine. The client is a specialist clinic in Munich, and Chordate's market consultants in Germany have been handling the processing. In November 2023, Chordate Medical entered into an agreement with a specialist clinic in Hamburg for Ozilia.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0548 SEK | 0.00% | +1.86% | -65.84% |
05-24 | Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Chordate Medical Receives Patent Approval in the US | CI |
1st Jan change | Capi. | |
---|---|---|
-65.84% | 2.54M | |
+8.50% | 220B | |
+24.13% | 149B | |
+33.45% | 113B | |
+4.14% | 65.75B | |
+14.10% | 52.43B | |
+4.08% | 50.47B | |
-4.98% | 38.54B | |
-3.34% | 34.12B | |
+22.18% | 30.87B |
- Stock Market
- Equities
- CMH Stock
- News Chordate Medical Holding AB
- Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine